Pediatric Pathways CME Details Volume 4

Contact e-Mail

Release date: March 15, 2012

Expiration date: March 15, 2013


Method of Participation


The articles in this document are an introduction to a CME opportunity that is available online. To obtain CME credit, go to, read all three complete articles and submit your answers to the review questions. A score of 80 percent correct or better will allow you to claim your credit. Credit letters will be mailed and if you do not receive one after two weeks from completion, please send an e-mail to


Estimated time to complete the activity: 1.0 hour.


Hardware/Software Requirements: None


System Requirements


Users can access this educational activity with any common Internet browser and connection.


Editorial Staff

  • Medical Editor: Michelle Kelly, MD
  • CME Director: Barb Anderson
  • Online Editor: Chad Hanson
  • Public Affairs Editor: Michael Felber
  • Editorial Board: David Bernhardt, MD; Amy Peterson, MD; Ellen Wald, MD

Target Audience and Scope of Practice


This program was designed to meet the needs of primary care providers including physicians, physician assistants, nurse practioners and other health care providers who participate in the care of the pediatric and adolescent patient.


Statement of Need


In addition to feedback from past conferences and grand rounds programs, results of a survey of Wisconsin-based physicians indicated great interest in the topics covered in this issue. Furthermore, the members of the editorial staff identified issues that have seen significant advances in recent years and that will be most applicable to learners’ clinical work.


Elements of Competence


This CME activity has been designed to change learner knowledge and performance and focuses on the American Board of Medical Specialties areas of medical knowledge and practice-based learning and improvement.


Overall Objective


Provide physicians and other health care professionals with up-to-date information on new trends and developments in the prevention and treatment of childhood and adolescent diseases.


Educational Objectives


At the conclusion of this educational activity, participants should be able to:

  1. Review state-of-the-art, evidence-based practices influencing the prevention, care and treatment of pediatric and adolescent infectious diseases. Participants will be able to independently and consistently identify sound medical practices and incorporate them into daily practice.
  2. Compare the latest practice recommendations to current clinical practice. Participants will be able to assess their current practices and determine if the research applies to their patient populations in order to evaluate the need to make changes to their standards of care.
  3. Identify points around current issues in pediatric and adolescent medicine. Participants will identify trends in pediatric medicine and formulate plans to incorporate them into their practices.

Credit Designation Statement


The University of Wisconsin School of Medicine and Public Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Accreditation Statement


The University of Wisconsin School of Medicine and Public Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Continuing Education Units


The University of Wisconsin-Madison as a member of the University Continuing Education Association (UCEA) authorizes this program for 1.00 education units (CEUs) or 1.0 hours.


Policy on Disclosure


It is the policy of the University of Wisconsin School of Medicine and Public Health that the faculty, authors, planners and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests in order to allow CME staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). For this educational activity all conflicts of interests have been resolved and detailed disclosures are listed below:


The following editors and authors report having no financial relationships with commercial interests and will not reference unlabeled or unapproved uses of drugs or devices in their articles: Barbara Anderson, Matthew Bell, Jason Ballak, David Bernhardt, Michael Felber, Chad Hanson, Michelle Kelly, Douglas McMahon, Amy Meyer, Amy Peterson, Ellen R. Wald.


Dr. James Gern discloses the following relationships with commercial interests: Centocor, Medimmune, Inc. (Consultant); AstraZeneca (Independent Contractor/Researcher; Boehringer Ingelheim, GlaxoSmithKline (Member of Advisory Committee or Review Pane). Dr. Gern will not reference unlabeled or unapproved uses of drugs or devices in his articles.


This activity is a collaboration between the University of Wisconsin School of Medicine and Public Health, Department of Pediatrics and the Office of Continuing Professional Development and the American Family Children's Hospital.


© 2012 by the Board of Regents of the University of Wisconsin System. All rights reserved.


No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic or mechanical, including photocopying or recording, with out the written permission of the Board of Regents of the University of Wisconsin.


Title IX and ADA Statement


The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin School of Medicine and Public Health fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in the educational activity is in need of accommodations, please notify Barbara Anderson in order to receive service. Please call (608) 263-8542.